Zhejiang Cheng Yi Pharmaceutical Co Ltd
SSE:603811
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhejiang Cheng Yi Pharmaceutical Co Ltd
SSE:603811
|
CN |
|
T
|
Tes Co Ltd
KOSDAQ:095610
|
KR |
Dividends
Dividend Yield
Zhejiang Cheng Yi Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Zhejiang Cheng Yi Pharmaceutical Co Ltd
Zhejiang Cheng Yi Pharmaceutical Co Ltd have decreased by 0%.
Payout Ratio
Zhejiang Cheng Yi Pharmaceutical Co Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
Zhejiang Cheng Yi Pharmaceutical Co Ltd is
.
Peers Comparison
Shareholder Yield
Price Appreciation
Price
Zhejiang Cheng Yi Pharmaceutical Co Ltd
| Average Annual Return | -7.58% |
| Standard Deviation of Annual Returns | 29.39% |
| Max Drawdown | -69% |
| Market Capitalization | 3.4B CNY |
| Shares Outstanding | 458 230 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Zhejiang Cheng Yi Pharmaceutical Co Ltd's latest stock split occurred on Jun 8, 2023
The company executed a 7-for-5 stock split, meaning that for every 5 shares held, investors received 7 new shares.
Before the split, Zhejiang Cheng Yi Pharmaceutical Co Ltd traded at 12.8786 per share. Afterward, the share price was about 12.42.
The adjusted shares began trading on Jun 8, 2023. This was stock split number 4 in Zhejiang Cheng Yi Pharmaceutical Co Ltd's history, following the previous one in Jun 4, 2021.